Adding ‘Cancer’ to Risk Calculator May Help Predict Stroke in AF
Adding “cancer” to the atrial fibrillation prediction model improved the predictability of...
atrial fibrillation
Risk Factors for LAAT in Patients With Atrial Fibrillation
Left atrial appendage depth (LAAD) and tachycardia bradycardia syndrome (TBS) are associated with...
Conference Highlights: Heart Rhythm 2021
New research was presented at Heart Rhythm 2021, the hybrid annual meeting of the Heart Rhythm...
Breast Cancer & A-Fib
“Unfortunately, among patients with breast cancer, healthy survivorship can be impacted by late...
Updated Stroke Prevention Guidelines
The American Heart Association and American Stroke Association (AHA/ASA) have updated guidelines...
The Increasing Burden of Atrial Fibrillation
Research suggests that atrial fibrillation (AF) is the most common heart rhythm disorder, but the...
Managing AF: A Look at Treating Specialty
About 2.3 million Americans are affected by atrial fibrillation and atrial flutter (AF), a...
ED Care of AF & Hospital Charges
The initial management of newly recognized atrial fibrillation and atrial flutter (AF) lasting...
Yoga Helps Patients Living With AF
A study involving patients with symptomatic paroxysmal atrial fibrillation (AF) suggests that yoga appears to reduce symptomatic AF and non-AF episodes. The analysis also suggests that yoga can help reduce the number of...
Trends in AF Among Hospitalized ACS Patients
Among patients hospitalized with an acute coronary syndrome (ACS), overall rates of atrial fibrillation (AF) and mortality from it decreased between 2000 and 2007, according to a study from Massachusetts. Despite the findings,...
Devices for Cardiac Rhythm Abnormalities: A Guideline Update
According to recent estimates, about 400,000 pacemakers and implantable cardioverter...
Newer Oral Anticoagulants Beneficial for Atrial Fibrillation
In patients with atrial fibrillation (AF), novel oral anticoagulants (NOACs) appear to provide greater overall clinical benefit when compared with vitamin K antagonists. A systematic review and meta-analysis found than NOACs...
